药学辅料手册Handbook of Pharmaceutical Excipients(6th,2009)6-3 热度: 相关推荐 582Povidone solubleactivedrugsmaybeincreasedbymixingwithpovidone.SeeTableII. Specialgradesofpyrogen-freepovidoneareavailableandhavebeenusedinparenteralformulations;seeSection14. SEM2:Excipient:povidoneK-15(PlasdoneK-15);manufacturer...
Featured excipient: flavor enhancing agents. Int J PharmCompound 2003; 7(1): 48–50.LeBlanc DT, Akers HA. Maltol and ethyl maltol: from the larch tree tosuccessful food additives. Food Technol 1989; 43(4): 78–84.General References21PJ Weller.Author228 January 2009.Date of RevisionMaltose...
药学辅料手册Handbook of Pharmaceutical Excipients(6th,2009)6-3 文档格式: .pdf 文档大小: 19.5M 文档页数: 150页 顶/踩数: 4/0 收藏人数: 9 评论次数: 0 文档热度: 文档分类: 行业资料--农业工程 系统标签: excipientspharmaceutical药学辅料ethylparabenfructose ...
PH 105Less than 50It is the most compressible of the PH products owing the smallest particle size. Well known as excipient for direct compression for granular or crystalline materials. When mixed with PH-101 or PH-102, specific flow and compression characteristics will be obtained. It has appli...
The ink constituents as solvents, APIs or modifying excipient can change viscosity, droplet size and influence the efficiency of powder binding. The process parameters as printing speed, droplet volume, distance from powder bed also play an important role in the product development and can have an...
(Caco-2) by decreasing the PgP-protein expression (20). However, the prediction of the realin vivoimpact is hardly possible, as it strongly depends on the applied excipient concentration, the binding-affinity, the therapeutic index of the drug, and even on the individual genetic protein ...
illustratedHandbookisa comprehensiveguidetotheuses,propertiesandsafetyofpharmaceuticalexcipientsandis anessentialreferenceforthoseinvolvedinthedevelopment,production,controlor regulationofpharmaceuticalpreparations. DataStandardscompilesandpaginateshundredsofimagesandDocBook XMLfilestoproducethishighlyillustratedHandbook. Sample...
deferiprone, may be used to treat lead toxicity. This invention also provides a process for preparing the low dose pharmaceutical composition, the process comprising: dissolving or adsorbing or blending deferasirox and at least one excipient to produce a dispersion of deferasirox; and processing the ...
A further preferred excipient is talc, which functions as glidant. All excipients comply with European Pharmacopeia, United States Pharmacopeia and Japanese Pharmacopeia. 9) A further embodiment relates to the pharmaceutical composition according to any embodiment from 7) to 9), wherein the tablet ...
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles...